The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Hepatitis C Virus Infection and the Risk of Coronary Disease
Open accessAbstract
BACKGROUND: The association between hepatitis C virus (HCV) infection and coronary artery disease (CAD) is controversial. We conducted this study to determine and quantify this association. METHODS: We used an established, national, observational cohort of all HCV-infected veterans receiving care at all Veterans Affairs facilities, the Electronically Retrieved Cohort of HCV Infected Veterans, to identify HCV-infected subjects and HCV-uninfected control subjects. We used the Cox proportional-hazards model to determine the risk of CAD among HCV-infected subjects and control subjects. RESULTS: We identified 82,083 HCV-infected and 89,582 HCV-uninfected subjects. HCV-infected subjects were less likely to have hypertension, hyperlipidemia, and diabetes but were more likely to abuse alcohol and drugs and to have renal failure and anemia. HCV-infected subjects had lower mean (+/- standard deviation) total plasma cholesterol (175 +/- 40.8 mg/dL vs. 198 +/- 41.0 mg/dL), low-density lipoprotein cholesterol (102 +/- 36.8 mg/dL vs. 119 +/- 38.2 mg/dL), and triglyceride (144 +/- 119 mg/dL vs. 179 +/- 151 mg/dL) levels, compared with HCV-uninfected subjects (P < .001 for all comparisons). In multivariable analysis, HCV infection was associated with a higher risk of CAD (hazard ratio, 1.25; 95% confidence interval, 1.20-1.30). Traditional risk factors (age, hypertension, chronic obstructive pulmonary disease, diabetes, and hyperlipidemia) were associated with a higher risk of CAD in both groups, whereas minority race and female sex were associated with a lower risk of CAD. CONCLUSIONS: HCV-infected persons are younger and have lower lipid levels and a lower prevalence of hypertension. Despite a favorable risk profile, HCV infection is associated with a higher risk of CAD after adjustment for traditional risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Chronic infections and coronary heart disease: is there a link?
Danesh, J., Collins, R., & Peto, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03079-1 · Cited by 1,211
Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 625
Increased COPD Among HIV-Positive Compared to HIV-Negative Veterans
Crothers, K., Butt, A. A., Gibert, C. L., Rodriguez-Barradas, M. C., Crystal, S., & Justice, A. C. (2006) · Chest · doi:10.1378/chest.130.5.1326 · Cited by 372
Self-citationInflammatory Reactions in the Pathogenesis of Atherosclerosis
Fan, J., & Watanabe, T. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.63 · Cited by 356
Ishizaka, N., Ishizaka, Y., Takahashi, E., Tooda, E.-I., Hashimoto, H., Nagai, R., & Yamakado, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07339-7 · Cited by 283
Development and Verification of a “Virtual” Cohort Using the National VA Health Information System
Fultz, S. L., Skanderson, M., Mole, L. A., Gandhi, N., Bryant, K., Crystal, S., & Justice, A. C. (2006) · Medical Care · doi:10.1097/01.mlr.0000223670.00890.74 · Cited by 256
Self-citationKolodgie, F. D., Virmani, R., Cornhill, J. F., Herderick, E. E., & Smialek, J. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90646-q · Cited by 213
Sanyal, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00551-3 · Cited by 178
Vassalle, C., Masini, S., Bianchi, F., & Zucchelli, G. C. (2004) · Heart · doi:10.1136/hrt.2003.018937 · Cited by 178
Targher, G., Bertolini, L., Scala, L., Zoppini, G., Zenari, L., & Falezza, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01646.x · Cited by 175
Justice, A. C., Lasky, E., McGinnis, K. A., Skanderson, M., Conigliaro, J., Fultz, S. L., Crothers, K., Rabeneck, L., Rodriguez-Barradas, M., Weissman, S. B., et al. (2006) · Medical Care · doi:10.1097/01.mlr.0000228003.08925.8c · Cited by 162
Self-citationSerum lipid pattern in chronic hepatitis C: histological and virological correlations
Siagris, D., Christofidou, M., Theocharis, G. J., Pagoni, N., Papadimitriou, C., Lekkou, A., Thomopoulos, K., Starakis, I., Tsamandas, A. C., & Labropoulou‐Karatza, C. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00655.x · Cited by 152
Rate and predictors of treatment prescription for hepatitis C
Butt, A. A., Justice, A. C., Skanderson, M., Rigsby, M. O., Good, C. B., & Kwoh, C. K. (2006) · Gut · doi:10.1136/gut.2006.099150 · Cited by 151
Self-citationEmerging relations between infectious diseases and coronary artery disease and atherosclerosis.
Fong, I. W. (2000) · PubMed · Cited by 139
Hepatitis B and C virus infection and the risk of atherosclerosis in a general population
Völzke, H., Schwahn, C., Wolff, B., Mentel, R., Robinson, D. M., Kleine, V., Felix, S. B., & John, U. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.010 · Cited by 129
Goulet, J. L., Fultz, S. L., McGinnis, K. A., & Justice, A. C. (2005) · AIDS · doi:10.1097/01.aids.0000192077.11067.e5 · Cited by 120
Self-citationAlyan, Ö., Kaçmaz, F., Özdemır, Ö., Deveci, B., Astan, R., Çelebi, S., & İlkay, E. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0459 · Cited by 105
Butt, A. A., Khan, U. A., McGinnis, K. A., Skanderson, M., & Kwoh, C. K. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00885.x · Cited by 102
Self-citationNo Association between Hepatitis C Virus Seropositivity and Acute Myocardial Infarction
Arcari, C. M., Nelson, K. E., Netski, D. M., Nieto, F. J., & Gaydos, C. A. (2006) · Clinical Infectious Diseases · doi:10.1086/507031 · Cited by 99
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt
Marzouk, D., Jun, S. A. S. S., Bakr, I., El‐Hoseiny, M., Abdel-Hamid, M., Rekacewicz, C., Chaturvedi, N., Mohamed, M. K., & Fontanet, A. L. (2006) · Gut · doi:10.1136/gut.2006.091983 · Cited by 97
Riordan, S. M., Skinner, N. A., Kurtovic, J., LOCARNINI, S. A., McIver, C. J., Williams, R. L., & Visvanathan, K. (2006) · Inflammation Research · doi:10.1007/s00011-006-0082-0 · Cited by 96
Bauman, J. L., Grawe, J. J., Winecoff, A. P., & Hariman, R. J. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb04003.x · Cited by 92
Hepatitis C Virus and Atherosclerosis in Patients With Type 2 Diabetes
Fukui, M., Kitagawa, Y., Nakamura, N., & Yoshikawa, T. (2003) · JAMA · doi:10.1001/jama.289.10.1245-b · Cited by 81
Kramer, J. R., Giordano, T. P., Souchek, J., & El‐Serag, H. B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.017 · Cited by 77
Reasons for non‐treatment of hepatitis C in veterans in care
Butt, A. A., Wagener, M. W., Shakil, A. O., & Ahmad, J. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00547.x · Cited by 76
Self-citationMomiyama, Y., Ohmori, R., Kato, R., Taniguchi, H., Nakamura, H., & Ohsuzu, F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.027 · Cited by 65
Cardiac effects of cocaine: a review.
Gradman, A. H. (1988) · PubMed · Cited by 61
Rates and predictors of hepatitis C virus treatment in HCV–HIV‐coinfected subjects
Butt, A. A., Justice, A. C., Skanderson, M., Good, C. B., & Kwoh, C. K. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03020.x · Cited by 38
Self-citationEffect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients
do Nascimento, M. M., Bruchfeld, A. N., Suliman, M. E., Hayashi, S. Y., Pecoits‐Filho, R., Manfro, R. C., Pachaly, M. A., Renner, L., Stenvinkel, P., Riella, M., et al. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000500017 · Cited by 38
Acute coronary syndrome and chronic infection in the Cork coronary care case–control study
Sheehan, J., Kearney, P. M., Sullivan, S. O., Mongan, C., Kelly, E., & Perry, I. J. (2004) · Heart · doi:10.1136/hrt.2003.031799 · Cited by 31
McGinnis, K. A., Skanderson, M., Levin, F. L., Brandt, C., Erdos, J., & Justice, A. C. (2008) · Medical Care · doi:10.1097/mlr.0b013e31817d69c2 · Cited by 19
Self-citation
Cited by
HIV and aging: time for a new paradigm.
Justice, A. C. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0041-9 · Cited by 309
Self-citationExtrahepatic manifestations of chronic hepatitis C virus infection
Cacoub, P., Gragnani, L., Comarmond, C., & Zignego, A. L. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.10.005 · Cited by 293
Extrahepatic manifestations of chronic hepatitis C virus infection
Cacoub, P., Comarmond, C., Domont, F., Savey, L., Desbois, A. C., & Saadoun, D. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115585942 · Cited by 291
Petta, S., Maida, M., Macaluso, F. S., Barbara, M., Licata, A., Craxì, A., & Cammà, C. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.09.007 · Cited by 254
Cardiovascular disease risk in an aging HIV population: not just a question of biology
So-Armah, K., & Freiberg, M. S. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000065 · Cited by 45
Metadata
- Authors
- Butt, A. A., Xiaoqiang, W., Budoff, M., Leaf, D., Kuller, L. H., & Justice, A. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-15
- Volume
- 49
- Issue
- 2
- Pages
- 225-232
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2150381969
- Cited by
- 276
- References
- 34
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.